Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.

Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A, Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM, Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabási AL, Beroukhim R, Kieff E, Cusick ME, Hill DE, Münger K, Marto JA, Quackenbush J, Roth FP, DeCaprio JA, Vidal M.

Nature. 2012 Jul 26;487(7408):491-5. doi: 10.1038/nature11288.

2.

[Are tumors caused by DNA viruses?].

Hirt B.

Pathol Microbiol (Basel). 1973;39(1):24-31. German. No abstract available.

PMID:
4349815
3.

Viral perturbations of host networks reflect disease etiology.

Gulbahce N, Yan H, Dricot A, Padi M, Byrdsong D, Franchi R, Lee DS, Rozenblatt-Rosen O, Mar JC, Calderwood MA, Baldwin A, Zhao B, Santhanam B, Braun P, Simonis N, Huh KW, Hellner K, Grace M, Chen A, Rubio R, Marto JA, Christakis NA, Kieff E, Roth FP, Roecklein-Canfield J, Decaprio JA, Cusick ME, Quackenbush J, Hill DE, Münger K, Vidal M, Barabási AL.

PLoS Comput Biol. 2012;8(6):e1002531. doi: 10.1371/journal.pcbi.1002531.

4.

The landscape of viral expression and host gene fusion and adaptation in human cancer.

Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E.

Nat Commun. 2013;4:2513. doi: 10.1038/ncomms3513.

5.

Virus-human cell interactomes.

Tafforeau L, Rabourdin-Combe C, Lotteau V.

Methods Mol Biol. 2012;812:103-20. doi: 10.1007/978-1-61779-455-1_6.

PMID:
22218856
6.

Patterns of somatic mutation in human cancer genomes.

Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR.

Nature. 2007 Mar 8;446(7132):153-8.

7.

Germline fitness-based scoring of cancer mutations.

Fischer A, Greenman C, Mustonen V.

Genetics. 2011 Jun;188(2):383-93. doi: 10.1534/genetics.111.127480.

8.

Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.

Gu Y, Wang H, Qin Y, Zhang Y, Zhao W, Qi L, Zhang Y, Wang C, Guo Z.

Mol Biosyst. 2013 Mar;9(3):467-77. doi: 10.1039/c2mb25528f.

PMID:
23344900
9.

Exploration of panviral proteome: high-throughput cloning and functional implications in virus-host interactions.

Yu X, Bian X, Throop A, Song L, Moral LD, Park J, Seiler C, Fiacco M, Steel J, Hunter P, Saul J, Wang J, Qiu J, Pipas JM, LaBaer J.

Theranostics. 2014 Jun 6;4(8):808-22. doi: 10.7150/thno.8255.

10.

De novo discovery of mutated driver pathways in cancer.

Vandin F, Upfal E, Raphael BJ.

Genome Res. 2012 Feb;22(2):375-85. doi: 10.1101/gr.120477.111.

11.

Systems biology of virus-host signaling network interactions.

Xue Q, Miller-Jensen K.

BMB Rep. 2012 Apr;45(4):213-20. Review.

12.

Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.

Wang E, Zaman N, Mcgee S, Milanese JS, Masoudi-Nejad A, O'Connor-McCourt M.

Semin Cancer Biol. 2015 Feb;30:4-12. doi: 10.1016/j.semcancer.2014.04.002. Review.

PMID:
24747696
13.

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.

Martin D, Gutkind JS.

Oncogene. 2008 Dec;27 Suppl 2:S31-42. doi: 10.1038/onc.2009.351. Review.

PMID:
19956178
14.

Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer.

Smith P.

Semin Cancer Biol. 2001 Dec;11(6):469-76. Review.

PMID:
11669609
15.

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Hua X, Xu H, Yang Y, Zhu J, Liu P, Lu Y.

Am J Hum Genet. 2013 Sep 5;93(3):439-51. doi: 10.1016/j.ajhg.2013.07.003.

16.

An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.

Chari R, Coe BP, Vucic EA, Lockwood WW, Lam WL.

BMC Syst Biol. 2010 May 17;4:67. doi: 10.1186/1752-0509-4-67.

17.

Poxvirus host range genes.

Werden SJ, Rahman MM, McFadden G.

Adv Virus Res. 2008;71:135-71. doi: 10.1016/S0065-3527(08)00003-1. Review.

PMID:
18585528
18.

Probabilistic model of the human protein-protein interaction network.

Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Barrette T, Kalyana-Sundaram S, Ghosh D, Pandey A, Chinnaiyan AM.

Nat Biotechnol. 2005 Aug;23(8):951-9.

PMID:
16082366
19.

Cloned Vero cell lines transfected with full-length A-segment or ORF1 cDNA sequence of IBDV.

Ye J, Chen Q, Zhou J, Li L.

Cell Biol Int. 2007 Feb;31(2):165-72.

PMID:
17137796
20.

Our changing view of the genomic landscape of cancer.

Bell DW.

J Pathol. 2010 Jan;220(2):231-43. doi: 10.1002/path.2645. Review.

Supplemental Content

Support Center